Nelson Peltz and Trian Fund Management have reportedly submitted a takeover bid to take Wendy's private after 15+ years as the company's largest activist holder and Non-Executive Chairman. A live-market practitioner case on the anatomy of an insider-led take-private: chain of custody, the specific special committee governance mechanics required under Delaware law, the take-private math against QSR LBO comparables, financing structure, and competing bidder probability.
Reporting attribution. This case study is based on public reporting from CNBC (Aug 12, 2026) that Nelson Peltz and Trian Fund Management have submitted a takeover bid for The Wendy's Company, plus follow-up reporting from Oliver Barnes at the Financial Times (Aug 12-13, 2026) that Trian is assembling a consortium including Abu Dhabi-based BlueFive Capital (Bugatti-Rimac backer) and Flynn Group (one of Wendy's largest franchisees), with a formal bid expected in the coming weeks. Trian has been preparing this bid since a February 2026 13D filing that specifically flagged Wendy's as "undervalued" and disclosed outreach to potential co-investors about strategic options including take-private. All Institute analysis is interpretive practitioner commentary on publicly reported facts.
Author disclosure: Philip A. Baratelli does not own WEN stock. The Institute has no commercial or advisory relationship with Wendy's, Trian, or any other party referenced in this case study.
The Institute number is $14.00/share. That is where a properly-advised MFW special committee can defend a sale of Wendy's to the Trian consortium: 11.0x on the Institute's conservative $460M full-year Adj EBITDA estimate, 85% premium over the $7.55 unaffected pre-bid price, $5.08B enterprise value. $14 matches Burger King's 2010 take-private multiple (the single most distressed QSR precedent of the past 15 years), sits at the floor of the stress-adjusted peer trading range, and is below every other QSR take-private in the modern era — so it is genuinely conservative and requires no reach from the fairness bank. Sources & Uses at the $14 base case are walked in Section 2.3; the three-methodology fair-value derivation is in Section 2.4 of the PDF. This is an insider-led take-private with a named consortium already assembling. Per FT reporting, Trian's consortium includes Abu Dhabi-based BlueFive Capital (Bugatti-Rimac backer — Middle East sovereign-wealth-adjacent) and Flynn Group (one of Wendy's largest franchisees). Peltz's 15-year board tenure and Trian's 16% position trigger Delaware's most demanding process protection standard (the MFW framework): independent special committee, independent legal counsel, independent financial advisor, majority-of-minority shareholder vote condition, full disclosure of interest conflicts. The customary "premium to unaffected" convention breaks in this case because the $7.55 unaffected price is itself depressed by Q2 operational stress and withdrawn guidance; the committee must defend on methodology, not on premium. The Institute expects the transaction to clear at $14–15/share after committee negotiation, with upside to $16 (11.5–12.0x) if Roark or another QSR-focused fund enters competitively. The transaction that emerges will be a case study in either well-executed MFW governance clearing at the fair price or in process failures that Delaware Chancery will unwind.
Understanding this transaction requires understanding the specific 15+ year history that brought Nelson Peltz to a controlling-insider position at Wendy's, and how that position specifically triggers the governance requirements the bid must navigate.
Nelson Peltz's involvement with Wendy's dates to 2008, when Triarc Companies (Peltz's holding company, which owned Arby's) merged with Wendy's International. The combined entity became Wendy's/Arby's Group. Peltz became Non-Executive Chairman. Trian Fund Management, the hedge fund Peltz co-founded with Peter May and Ed Garden, became the largest shareholder. In 2011, Wendy's/Arby's separated Arby's (sold to Roark Capital), and the surviving company became The Wendy's Company — the specific entity that is now the subject of the take-private bid.
Trian holds approximately 16% of Wendy's shares as of the current period (per FT reporting) — the largest single shareholder position by a substantial margin, though modestly reduced from historical levels closer to 19-20%. Peltz has served as Non-Executive Chairman continuously since the 2008 merger. His son Matthew Peltz has served on the Board. Trian's presence has shaped a set of strategic decisions including capital return programs, franchise system growth, international expansion, and technology investments.
Trian is not simply a large shareholder submitting an outside bid. Trian is a specific insider — Peltz has been Chairman during the same period he was making the specific decision to bid for the company. That specific configuration is the specific fact pattern that triggers Delaware's most demanding process protection standard, treated in detail in Section 3 below.
Practitioner note on the specific "activist-to-acquirer" transition. Trian's transition from largest activist shareholder to acquiring party fits a specific pattern that has become more common over the past decade — activists who cannot achieve desired strategic outcomes through Board pressure eventually attempt to acquire the specific target outright and execute the strategy under private ownership. Bill Ackman's Howard Hughes / Ackman Sports acquisition attempt (2024) and Carl Icahn's specific take-private attempts (Blockbuster, Motorola) fit the same pattern. The specific transition raises specific fiduciary questions the standard sell-side process does not have to answer.
The specific numbers underneath the reported bid, walked with the Institute's Show-the-Math discipline. All figures are approximate and based on publicly reported data.
| Line | Value | Note |
|---|---|---|
| Pre-bid unaffected share price | $7.55 | Aug 11, 2026 close (last day before CNBC report) |
| Diluted shares outstanding | 190.7M | Per Q2 2026 10-Q (as of July 31, 2026) |
| Pre-bid market cap | $1.44B | 190.7M × $7.55 |
| Net financial debt | $2.41B | $2.75B gross debt less $341M cash (Q2 10-Q) |
| Pre-bid enterprise value | $3.85B | Market cap + net financial debt |
| Full-year 2026 Adj EBITDA (Institute estimate) | $460M | H1 actual $235M + back-half projected $225M; company withdrew guidance |
| Pre-bid EV / EBITDA | 8.4x | $3.85B / $460M — on the conservative EBITDA estimate |
QSR take-privates historically clear at 25-40% premiums to pre-bid market prices. That convention breaks in this case because the $7.55 unaffected price is itself depressed by Q2 operational stress and withdrawn guidance — well below the level standard valuation methodologies support. Section 2.4 of the PDF walks the methodologies. The Institute base case is $14/share (11.0x on $460M EBITDA, 85% premium over $7.55), matching the low end of the stress-adjusted peer trading range and the Burger King 2010 take-private precedent — the single most distressed QSR precedent in the past 15 years. The special committee must defend on methodology, not on premium.
| Scenario | Premium | Per-share | Equity value | Enterprise value | EV / EBITDA |
|---|---|---|---|---|---|
| Institute base case — fair-price floor | 85% | $14.00 | $2.67B | $5.08B | 11.0x |
| Committee negotiation midpoint | 100% | $15.10 | $2.88B | $5.29B | 11.5x |
| Roark competing bid (stress-adjusted peer midpoint) | 116% | $16.30 | $3.11B | $5.52B | 12.0x |
Why the Institute base case is $14. Three independent valuation methodologies (peer trading, precedent transactions, DCF) each point to fair value at or above $14/share. $14 at 11.0x is the floor — the lowest price the special committee can defend, matching Burger King 2010, sitting at the bottom of the stress-adjusted peer trading range, and requiring no reach from the fairness bank. Any price meaningfully below this floor invites Chancery litigation and loses on the merits.
Trian's 16% position means Trian rolls approximately $427M of existing shares (30.5M × $14) into the new private-company equity as a non-cash contribution. Trian and the consortium (BlueFive Capital, Flynn Group, additional co-investors) then fund the cash purchase of the remaining 160.2M public shares. To keep Uses and Sources apples-to-apples, the table below uses the cash-in/cash-out convention: the Trian rollover is shown as a memo item, not double-counted as a Uses purchase offset by a Sources contribution.
| Uses — cash out ($M) | Value | What's in it |
|---|---|---|
| Cash to non-Trian public shareholders | 2,243 | 160.2M non-Trian shares × $14.00 (190.7M total less 30.5M Trian shares that roll) |
| Working capital to balance sheet | 75 | Operating liquidity for the private company post-closing |
| Debt costs | 32 | New-holdco arranger + financing legal + rating agency (~20) + WBS noteholder consent fee (~12) |
| Trian side (buy-side) transaction fees | 29 | Buy-side banker (~14, 0.28% of EV) + M&A legal (~10) + diligence firms (~3) + tax adviser (~2) |
| Special committee / sell-side transaction costs | 58 | Ordinary M&A legal (~10) + financial advisor (~16, 0.32% of TV) + special committee independent counsel & fairness bank (~10 MFW increment) + D&O tail (~10) + R&W insurance (~9) + proxy solicitor & SEC filings (~3) |
| Total cash uses | 2,437 | Closing cash outlay under Option B at $14.00/share |
| Sources — cash in ($M) | Value | Note |
|---|---|---|
| New cash equity from consortium (BlueFive + Flynn + others + fresh Trian) | 1,637 | Consortium cash equity per FT reporting; funds the cash portion of the deal above and beyond the new holdco debt |
| New holdco debt (first-lien term loan + mezzanine + PIK) | 800 | ~1.75x EBITDA at holdco level under Option B; sponsor could push to ~$1.1B to reduce cash equity need |
| Total cash sources | 2,437 | Matches cash uses |
| Memo — total equity capital at $14.00/share ($M) | Value |
|---|---|
| New cash equity from consortium (from Sources above) | 1,637 |
| Trian rollover equity (30.5M shares × $14.00, non-cash) | 427 |
| Total equity capital in the deal | 2,064 |
The consortium equity check at $14.00/share. Total equity capital committed — Trian rollover of $427M plus new consortium cash of $1,637M — is $2,064M. That is the equity Trian must assemble from BlueFive, Flynn, and any additional co-investors to fund a price the special committee can defend. Two dials the sponsor can turn if the cash portion of the check is too large: (a) push holdco debt above the modest $800M in Option B (feasible up to ~$1.1B before interest coverage tightens below 2.5x, reducing the cash equity need by ~$300M), or (b) walk. Trian has been preparing this bid since February 2026 with a named consortium already assembling — walking is not the base case. BlueFive's Middle East sovereign-adjacent capital pool is deep enough to fund its allocated share.
The specific insider status of Peltz and Trian means this transaction is governed by Kahn v. M&F Worldwide Corp. (Del. 2014) — the specific Delaware Supreme Court decision that established the specific process protections required for controlling-shareholder or specific insider-led transactions to receive business judgment rule protection rather than the more demanding entire fairness standard.
Under MFW, for an insider-led transaction to receive business judgment rule protection, the specific transaction must be:
| # | MFW condition | Specific requirement |
|---|---|---|
| 1 | Conditioned on approval by independent special committee | Committee formed at outset; empowered from the beginning |
| 2 | Committee is independent | No specific ties to insider group; disclosed on the record |
| 3 | Committee empowered to reject and select advisors | Real "just say no" power, not consulting role |
| 4 | Committee meets duty of care in negotiation | Documented negotiation process, market check where appropriate |
| 5 | Conditioned on majority-of-minority approval | Vote of shares held by non-insiders required for approval |
| 6 | No coercion of minority shareholders | Fair disclosure and process for the vote |
The specific expected sequence based on MFW-compliant transactions in similar circumstances:
The specific practitioner point. Any specific process failure at any specific MFW condition converts the transaction from business judgment review to entire fairness review — the specific standard under which the burden of proof shifts to the specific defendants (the insider group and the Board) to prove the transaction was fair in both process and price. Entire fairness litigation is expensive, time-consuming, and often produces specific damages awards or transaction unwinds. Well-executed MFW protection is essential; poorly-executed MFW protection specifically creates the litigation exposure the process was designed to eliminate.
The specific market has a substantial history of QSR take-privates over the past 15 years. Each specific transaction produces a specific implied multiple range for the Wendy's specific bid.
| Target (year) | Acquirer | Transaction value | Implied EV/EBITDA | Notes |
|---|---|---|---|---|
| Burger King (2010) | 3G Capital | $4.0B | 11x | Classic 3G operational-transformation playbook; roll-up eventually into RBI |
| Panera Bread (2017) | JAB Holding | $7.5B | 18x | Fast-casual premium; JAB private consumer platform |
| Popeyes (2017) | Restaurant Brands Intl. | $1.8B | 21x | Strategic add to RBI/3G platform; growth premium |
| Dunkin' Brands (2020) | Inspire Brands (Roark) | $11.3B | 17x | Roark consumer platform; rate environment factor |
| Arby's (2011, private already) | Roark Capital | $430M | 7x | Distressed sale from Wendy's/Arby's; became Inspire platform anchor |
| Wendy's (base case, 35% premium) | Trian + co-sponsor | $6.6B | 14.7x | Reference math from Section 2 |
Practitioner read on the comp set. The Institute base case of 14.7x EV/EBITDA for Wendy's sits below the specific mid-cycle QSR take-private multiples (Panera 18x, Popeyes 21x, Dunkin' 17x) but above the specific distressed / operationally-challenged multiples (Burger King 11x, Arby's 7x). The specific 14.7x reflects Wendy's specific position: mature brand with stable but not accelerating growth, mostly-franchised model (positive for EBITDA quality), specific operational challenges the specific take-private is designed to address, and a specific rate environment that limits LBO leverage capacity compared to the 2017-2020 cycle. A specific competing bidder could push the specific multiple to 16-18x; absent competition, the specific committee may accept 14-15x if the specific process is defensible.
QSR LBOs in the current rate environment (early-to-mid 2026) typically clear with specific leverage ratios in the 5.5-7.0x range depending on the specific target's cash flow characteristics. Wendy's specific mostly-franchised model produces relatively stable free cash flow, which supports leverage at the specific upper end of the range.
| Layer | Amount | Multiple of EBITDA | Notes |
|---|---|---|---|
| First-lien term loan (senior secured) | $1.8B | 4.0x | Priced at SOFR + 300-450 bps |
| Second-lien or unitranche (subordinated secured) | $500M | 1.1x | Priced at SOFR + 550-750 bps |
| Senior unsecured notes or PIK | $700M | 1.6x | Priced 8-11% depending on structure |
| Total debt financing | $3.0B | 6.7x | Aggressive but defensible for QSR |
| New equity from Trian + co-sponsors | $2.9B | n/a | Fund equity + LP co-investors |
| Trian rollover equity | $685M | n/a | Existing 19% position converts |
| Total funding at closing | $6.6B | n/a | Enterprise value at 35% premium |
Consumer LBOs of this size typically involve syndicates of 4-8 lead lenders drawn from the bulge-bracket lender group that regularly leads consumer LBO transactions. Direct lending firms participate at the mezz or unitranche layers. Lender selection is driven by relationships with the sponsor rather than by the target.
The specific financing risk. In the current rate environment, LBO financing markets have periods of specific volatility. A specific market disruption during the specific 60-120 day period between signing and closing could materially affect the specific financing certainty. Modern take-private deals typically address this through specific "specified events" carve-outs rather than broad market MAC provisions — but the specific market MAC negotiation for this specific transaction will be watched closely by other prospective take-private buyers in the current cycle.
The specific special committee is required to conduct some form of market check under MFW. That specific market check will surface which competing bidders, if any, would emerge.
The specific highest-probability competing bidder is Roark Capital / Inspire Brands. Roark's specific QSR platform strategy, existing Arby's ownership (adjacent brand that was previously joint with Wendy's), and specific ability to execute would make Wendy's a strategic fit at the specific right price. A specific Roark bid would likely push the transaction multiple to 16-18x EV/EBITDA, producing a specific per-share price in the $20-22 range (60-75% premium over pre-bid).
If Roark does not emerge, the transaction likely clears at the specific Trian bid level (14-16x, $16-19/share) with the specific market check producing no competing bids.
The specific market-observable events that will indicate transaction trajectory:
| Event | Timing | What it signals |
|---|---|---|
| Wendy's Board response | Days-to-weeks | Special committee formation confirms MFW-compliant process is being executed. Failure to form triggers specific litigation risk. |
| Independent advisor selection | 1-3 weeks | Which specific bank and law firm the committee retains signals process seriousness. Elite boutique bank = specific commitment to independence. |
| Trian co-sponsor announcement | 2-8 weeks | Which specific PE fund partners with Trian tells the market about the specific capital structure and probable post-closing strategy. |
| Market check activity | 4-12 weeks | Any specific competing bid announcement (Roark most likely). Absence of competing bids after full check confirms Trian bid clears. |
| Definitive agreement | 2-4 months | Specific terms of the specific merger agreement disclosed. Read the MFW protections, financing conditions, and any go-shop provisions. |
| Proxy filing | 3-5 months | Full disclosure of the specific negotiation history, alternatives considered, and D&O interests. The specific reading discipline for the background section is where the specific process quality is documented. |
| Majority-of-minority vote | 4-6 months | The specific final MFW protection. Approval clears the transaction; rejection kills it. |
| Closing | 5-8 months | Subject to specific financing, regulatory, and closing conditions. |
The specific practitioner takeaways from this transaction: